← Leaderboards
Jennifer Ann Slyker
University Of Washington
$3,816,347
Attributed
$4,523,523
Total exposure
7
Grants
7
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $892.6K · FY2010–25$1M$750K$500K$250K$0
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$4,523,523 · 7
By mechanism
R21$1,299,272 · 3
R01$1,202,470 · 1
P01$1,194,341 · 1
K01$615,557 · 1
R34$211,883 · 1
Top collaborators
- Cheryl Liane Day2 shared
- Dalton Chekoko Wamalwa1 shared
Most similar at University Of Washington
Same institution · by research overlap
- Rachel L. Winer$10,191,453
- Steve I Perlmutter$12,978,589
- Beti Thompson$30,192,370
- Laura A Koutsky$14,115,377
- Nancy B. Kiviat$21,349,193
Others in their field
Top investigators on “Cytomegalovirus”
- Constance Ann Benson · University Of California, San Diego$154,530,762
- Curtis L Meinert · Johns Hopkins University$72,267,482
- Louis J. Picker · Oregon Health And Science University$67,787,971
- Robert Turner Schooley · University Of Colorado Denver$42,307,156
- Dan H. Barouch · Fred Hutchinson Cancer Center$34,316,808
- Jay A Nelson · Oregon Health & Science University$28,085,685
Research focus
CytomegalovirusChildImmuneInfectionImmunologicsCytomegalovirus InfectionsKenyaViral Load ResultLifeDiagnosisBloodTherapy DesignPathogenInfantPlasmaViremiaClinical TrialsAntiretroviral TherapyWomanSpecimenPregnancyAreaMorbidity - Disease RateAfrica South Of The Sahara
Grant awards (16)
Identifying critical determinants of vaccine-induced cellular and humoral immunity from birth through childhood in HIV-exposed and unexposed children$577,777
R01 · FY2025 · AI · contact PI
The effect of cytomegalovirus, inflammation, and immune activation on neurodevelopment in children exposed to maternal HIV infection$301,775
P01 · FY2025 · HD · contact PI
Identifying critical determinants of vaccine-induced cellular and humoral immunity from birth through childhood in HIV-exposed and unexposed children$624,693
R01 · FY2024 · AI · contact PI
Planning grant for CMV suppression to reduce mortality in hospitalized, HIV-exposed children$211,883
R34 · FY2023 · AI · contact PI
The effect of cytomegalovirus, inflammation, and immune activation on neurodevelopment in children exposed to maternal HIV infection$892,566
P01 · FY2022 · HD · contact PI
Epstein-Barr virus replication, malaria and clinical outcomes in hospitalized HIV infected children$194,375
R21 · FY2021 · HD · contact PI
Epstein-Barr virus replication, malaria and clinical outcomes in hospitalized HIV infected children$233,250
R21 · FY2020 · HD · contact PI
CMV viremia and mortality in hospitalized HIV-infected children$202,761
R21 · FY2019 · HD · contact PI
CMV as a cause or co-pathogen in cervicitis$194,375
R21 · FY2019 · AI · contact PI
CMV viremia and mortality in hospitalized HIV-infected children$241,636
R21 · FY2018 · HD · contact PI
CMV as a cause or co-pathogen in cervicitis$232,875
R21 · FY2018 · AI · contact PI
Vertical CMV transmission in the setting of maternal HIV-1 infection in Kenya$127,116
K01 · FY2014 · AI · contact PI
Vertical CMV transmission in the setting of maternal HIV-1 infection in Kenya$127,116
K01 · FY2013 · AI · contact PI
Vertical CMV transmission in the setting of maternal HIV-1 infection in Kenya$127,116
K01 · FY2012 · AI · contact PI
Vertical CMV transmission in the setting of maternal HIV-1 infection in Kenya$127,116
K01 · FY2011 · AI · contact PI
Vertical CMV transmission in the setting of maternal HIV-1 infection in Kenya$107,093
K01 · FY2010 · AI · contact PI